In this article, new recommendations were made that changed the previous monitoring paradigm. More importantly, it has repositioned hydroxychloroquine from one of the safest medications that rheumatologists use to a drug that can have potentially significant ocular morbidity (if used in doses greater than 5 mg per kilogram and or for prolonged periods of time). Hyperpigmentation of the skin due to hydroxychloroquine Does chloroquine decrease potassium levels Plaquenil and stomach ulcers Calcium loss hydroxychloroquin therapy Hydroxychloroquine. Baseline assessment. Within one year of starting hydroxychloroquine, you may be invited to a baseline screening. have a test called a visual field test. In this test, one eye is tested at a time while the. other is temporarily covered with a patch. You will Abnormal test is the visual field test, you may be asked to repeat it to make sure of the results. You will be told if any other tests are necessary and when you should be screened again. In cases of possible retinopathy, you will be recommended to continue taking 8 9 Macular Society Eye screening for patients taking hydroxychloroquine Of course the aim is avoid drug related retinal toxicity, which on ophthalmic examination, appears as the classic Bull’s eye change affecting the macula. Once retinal toxicity from hydroxychloroquine occurs, it is thought that the retinal changes are permanent and the disease can progress even if hydroxychloroquine is stopped for 1 to 3 years. The previous AAO guideline recommended screening every 12 months. It has become fairly common practice for most rheumatologists to recommend that patients being treated with hydroxychloroquine be seen for formal visual field evaluation once or twice a year to monitor for retinal toxicity. Hydroxychloroquine baseline eye exam Baseline Retinal Examinations in Patients With Systemic., Eye screening for patients taking hydroxychloroquine Plaquenil Plaquenil and cannabisWhat are symptoms of plaquenil eye problemsPlaquenil 400 mg dailyPlaquenil and oral surgeryPlaquenil treatment 1cd 10 Is there a diagnosis for a baseline exam before patient starts plaquenil? Zella Posted Wed 05th of September, 2012 AM Do you only code the condition such as rheumatoid arthritis or sarcoidosis when coding an exam, vf or oct prior to patient starting high risk medication. or is there a V code for premedication exam? Is there a diagnosis for a baseline exam before patient.. My Take on New Ocular Screening Guidelines for Plaquenil.. How to Succeed in Plaquenil Screenings. Apr 20, 2011 Remember, any patient who is at a high risk for Plaquenil toxicity should be examined on an annual basis following the baseline exam. The goal of monitoring/screening is to identify early macular damage prior to irreversible vision loss or even before visible signs of bull’s eye maculopathy. Eye damage due to Plaquenil is not common,” he says. “Rarely will anybody who has good vision and minimal symptoms develop loss of central vision or ability to read if annual screening is done and visual are symptoms reported as soon as they occur so the medication can be stopped if toxicity occurs. A 57-year-old female presented to the Ophthalmology clinic at UIHC complaining bilateral central photopsias for the past two years. She suffered from Sjogren syndrome and inflammatory arthritis and was currently treated with prednisone and methotrexate. She was previously treated with hydroxychloroquine Plaquenil 200mg bid 6.5mg/kg for 10 years, which was stopped one year prior to.